An overview of FDA-approved vaccines & their innovators
Introduction: A survey of FDA-approved biologicals focused upon the development of immunotherapies over time to gain insight on the challenges and trends of vaccine development today. Areas covered: A total of 135 different immune-based therapies were broadly divided into passive or active immunothe...
Main Authors: | Rebekah H. Griesenauer, Michael S. Kinch |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1383159 |
Similar Items
-
Anamnestic response against bovine viral diarrhea virus and bovine herpesvirus type 1 in young Holstein heifers vaccinated with four different commercial formulations
by: Viviani Gomes, et al.
Published: (2023-07-01) -
The Specific Immune Response after Vaccination against Neonatal Calf Diarrhoea Differs between Apparent Similar Vaccines in a Case Study
by: Román Gonzalez, et al.
Published: (2021-04-01) -
Addressing barriers to vaccine acceptance: an overview
by: Noni E. MacDonald, et al.
Published: (2018-01-01) -
Immunity induced by valine-glycine repeat protein G imparts histoprotection of vital body organs against Acinetobacter baumannii
by: Saeed Alipouri, et al.
Published: (2022-03-01) -
The durability of vaccine-induced protection: an overview
by: Vipin M. Vashishtha, et al.
Published: (2024-12-01)